We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Management of Rabies in Humans.
- Authors
Jackson, Alan C.; Warrell, Mary J.; Rupprecht, Charles E.; Ertl, Hildegund C.J.; Dietzschold, Bernhard; O'Reilly, Michael; Leach, Richard P.; Fu, Zhen F.; Wunner, William H.; Bleck, Thomas P.; Wilde, Henry
- Abstract
Rabies is a fatal disease in humans, and, to date, the only survivors of the disease have received rabies vaccine before the onset of illness. The approach to management of the rabies normally should be palliative. In unusual circumstances, a decision may be made to use an aggressive approach to therapy for patients who present at an early stage of clinical disease. No single therapeutic agent is likely to be effective, but a combination of specific therapies could be considered, including rabies vaccine, rabies immunoglobulin, monoclonal antibodies, ribavirin, interferon-a, and ketamine. Corticosteroids should not be used. As research advances, new agents may become available in the future for the treatment of human rabies.
- Subjects
RABIES; DISEASE management
- Publication
Clinical Infectious Diseases, 2003, Vol 36, Issue 1, p60
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1086/344905